Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aduro, Adverum, Akebia, Angion, Athersys, Baudax, Bicycle, Biontech, Corcept, Delmar, Nabriva, Pfizer, Redhill, Regeneron, Sanofi, TG Therapeutics.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Mallinckrodt, Masimo.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: ADC, Akari, Astrazeneca, Athersys, Azurrx, BMS, Calcimedica, Eiger, Flexion, Ipsen, Kubota, Lilly, Merck, Novartis, Synairgen, TG.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Helius Medical Technologies, Sigrid Therapeutics, Xenex.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Agios, Bellus, Gilead, GSK, Janssen, Jazz, Leo, Lilly, Mallinckrodt, Mesoblast, Morphosys, Novartis, Palatin, Sanofi, Silence, Soligenix, Spectrum, Urogen, Vertex, Yuhan.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Castle Biosciences, Hancock Jaffe, Istar Medical.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biontech, Cadent, Chimerix, Corbus, Destiny, Dynavax, Erytech, Geneone, Gilead, Gracell, Inovio, Pfizer, United Therapeutics, Windtree.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Astrazeneca, Atyr, CTI Biopharma, Daiichi Sankyo, Hua Medicine, Immutep, Regeneron, Romark, Sanofi, Theravance.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Archerdx, Thrive Earlier Detection.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Apellis, Bioxcel, Blueprint, Genentech, Generex, I-Mab, Innate, Innovent, Inovio, Morphosys, Ocular, Orchard, R-Pharm, Rafael, Spectrum.